Help us promote and run our support groups in Cape Town and Gauteng by Donating Now

Genetic testing of Huntington’s Disease can be performed at any stage of development, even before the onset of symptoms

WELCOME To

HUNTINGTONS ASSOCIATION OF SOUTH AFRICA

Huntington’s disease (HD) is a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline and dementia. It typically becomes noticeable in middle age. HD is the most common genetic cause of abnormal involuntary writhing movements called chorea, and indeed the condition used to be called Huntington’s chorea. It is caused by an autosomal (there is an equal number of copies of the chromosome in males and females) dominant mutation on either of an individual’s two copies of a gene called Huntingtin, which means any child of an affected parent has a 50% risk of inheriting the disease. Physical symptoms of Huntington’s disease can begin at any age from infancy to old age, but usually begin between 35 and 44 years of age. About 6% of cases start before the age of 21 years; they progress faster and vary slightly.

Please register here on our private and confidential database of individuals and families affected by Huntingtons Disease

/g>

Please register here if you’re a medical or other professional involved in, or considering being involved in, the Huntingtons fraternity

Please register here on our private and confidential database of individuals and families affected by Huntingtons Disease

Support Us!

The funds we raise are used for:

  • Maintaining our online channels (this website and Facebook Page).
  • Promoting and running our support groups in Cape Town and Gauteng communities.
  • Collecting and gathering information through online associations and, in certain cases, attending conferences and/or pioneering companies.

Our Vision is to have all Huntingtons patient and their loved-ones aware of the latest breakthroughs towards finding a cure.

TREATMENT NEWS

Generation HD1

Generation HD1

The GENERATION HD1 study will evaluate the efficacy and safety of…

It’s never too early to take a proactive approach and help those in need of support